Furthermore, the high incidence of TERT mutations and TERT promoter methylation in high grade IDH2 tumours, suggests that these events, through activation of telomerase, have prevented the senescent phenotype and bring about high-grade IDH2 tumours. This evidence concerns the gene IDH2 and neoplasm.